Carbamazepine and lamotrigine-induced stevens Johnson syndrome: A comprehensive review

Read full text Summarise with VIRAT
Authors: Meghana Kanaparthi, Hema Dovari, Nadia Syed, Atufa Juveriya Mohammad, Dhanush Bellapu, Padmalatha Kantamaneni
Cited by: 0
References: 19

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Stevens-Johnson syndrome (SJS) is a rare but serious skin reaction to medications. It involves widespread skin damage and detachment [1]. Among the drugs used to treat epilepsy, carbamazepine and lamotrigine often trigger SJS, especially in the first few weeks of treatment [2]. Since these medications are commonly prescribed for epilepsy, bipolar disorder, neuropathic pain, and mood disorders, SJS is a significant safety concern [3]. The development of SJS involves genetic factors, immune responses, and how the body processes the drugs [4]. Recognizing early symptoms, stopping the offending drug immediately, and providing timely supportive care are crucial for better outcomes [5]. In most cases, the condition starts with nonspecific flu-like symptoms such as fever, fatigue, and sore throat. This is followed by the appearance of a painful rash, blistering of the skin, and involvement of the mucous membranes, which can quickly progress to widespread skin loss and serious systemic complications [5].

Fields of Study & Subjects

Drug-Induced Adverse Reactions Epilepsy research and treatment Contact Dermatitis and Allergies

Publication details

Journal / source
International Journal of Pharmacology and Clinical Research
Volume
8
Issue
2
Pages
18–23
Publication date
1 February 2026
Language
EN